Gender Difference in Perceived Symptoms and Laboratory Investigations in Suspected and Confirmed COVID-19 Cases: A Retrospective Study.
COVID-19 suspected cases
gender difference
phone triage
Journal
Journal of primary care & community health
ISSN: 2150-1327
Titre abrégé: J Prim Care Community Health
Pays: United States
ID NLM: 101518419
Informations de publication
Date de publication:
Historique:
entrez:
19
8
2021
pubmed:
20
8
2021
medline:
24
8
2021
Statut:
ppublish
Résumé
Evaluating gender-specific effects of COVID-19 is important to develop effective therapeutic strategies. The aim of this study was to explore gender difference in perceived symptoms and laboratory investigations in suspected and confirmed cases. This is a retrospective study that included data from suspected COVID-19 patients during the first wave of the pandemic. Participants using the phone triaging system at Kasralainy outpatient clinics were included. The analyzed data included patient history and results of nasopharyngeal swab and laboratory data. Out of 440 COVID-19 suspected cases, 56.36% were females. The perceived COVID-19 symptoms showed no significant gender difference in suspected cases while in confirmed cases females were 4 times more likely to complain of cough [OR (95% CI) 3.92 (1.316-11.68), Gender differences were found in laboratory markers in COVID-19 suspected and confirmed cases and in perceived symptoms in confirmed cases.
Sections du résumé
BACKGROUND
Evaluating gender-specific effects of COVID-19 is important to develop effective therapeutic strategies. The aim of this study was to explore gender difference in perceived symptoms and laboratory investigations in suspected and confirmed cases.
METHODS
This is a retrospective study that included data from suspected COVID-19 patients during the first wave of the pandemic. Participants using the phone triaging system at Kasralainy outpatient clinics were included. The analyzed data included patient history and results of nasopharyngeal swab and laboratory data.
RESULTS
Out of 440 COVID-19 suspected cases, 56.36% were females. The perceived COVID-19 symptoms showed no significant gender difference in suspected cases while in confirmed cases females were 4 times more likely to complain of cough [OR (95% CI) 3.92 (1.316-11.68),
CONCLUSION
Gender differences were found in laboratory markers in COVID-19 suspected and confirmed cases and in perceived symptoms in confirmed cases.
Identifiants
pubmed: 34407661
doi: 10.1177/21501327211039718
pmc: PMC8381412
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21501327211039718Références
Oncotarget. 2017 Jan 3;8(1):268-284
pubmed: 27902485
Front Immunol. 2018 Aug 27;9:1931
pubmed: 30210492
PLoS One. 2021 Jan 13;16(1):e0245556
pubmed: 33439908
Exp Ther Med. 2017 Apr;13(4):1431-1437
pubmed: 28413489
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74
pubmed: 24367114
Gerontology. 2021;67(3):255-266
pubmed: 33406518
Ann N Y Acad Sci. 1995 Dec 29;771:131-58
pubmed: 8597393
Mayo Clin Proc. 2020 Aug;95(8):1710-1714
pubmed: 32753145
J Womens Health (Larchmt). 2021 Mar;30(3):393-404
pubmed: 33416429
Adv Immunol. 2012;114:77-106
pubmed: 22449779
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
BMJ Open. 2020 Oct 6;10(10):e040129
pubmed: 33028563
Med Mal Infect. 2020 May;50(3):243-251
pubmed: 31727466
J Immunol. 2010 Feb 1;184(3):1410-8
pubmed: 20042589
Dev Cell. 2020 Jun 8;53(5):514-529.e3
pubmed: 32425701
Sci Rep. 2017 Jun 28;7(1):4330
pubmed: 28659608
BMC Pulm Med. 2021 Mar 20;21(1):96
pubmed: 33743654
J Neuroimmune Pharmacol. 2021 Mar;16(1):38-47
pubmed: 33405098
Biol Sex Differ. 2020 May 4;11(1):24
pubmed: 32366281